Jose Marenco

Jose Marenco

Auto-generated profile, based on publicly available information

Jose Marenco

Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2019 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
JMJose Marenco
Jose Marenco
COClement Orczyk
Clement Orczyk
TCTom Collins
Tom Collins
CMCaroline Moore
Caroline Moore
MEMark Emberton
Mark Emberton

1 November 2021 in European Urology Focus
Verified
Journal Article
Closed access
JMJose Marenco
Jose Marenco
ACAna Calatrava
Ana Calatrava
JCJuan Casanova
Juan Casanova
FCFrancesco Claps
Francesco Claps
JMJuan Mascaros
Juan Mascaros
JRJose Rubio
Jose Rubio

1 June 2022 in Asian Journal of Urology
Verified
Journal Article
Open access
SPStefano Puliatti
Stefano Puliatti
AEAhmed Eissa
Ahmed Eissa
Enrico CheccucciEnrico Checcucci
Enrico Checcucci
PPPietro Piazza
Pietro Piazza
MAMarco Amato
Marco Amato
SMSalvatore Micali
Salvatore Micali
Kidney cancers account for approximately 2% of all newly diagnosed cancer in 2020. Among the primary treatment options for kidney cancer, urologist may choose between radical or partial nephrectomy, or ablative therapies. Nowadays, robotic-assisted partial nephrectomy (RAPN) for the management of renal cancers has gained popularity, up to being considered the gold standard. However, RAPN is a challenging procedure with a steep learning curve. In this narrative review, different imaging technologies used to guide and aid RAPN are discussed. Three-dimensional visualization technology has been extensively discussed in RAPN, showing its value in enhancing robotic-surgery training, patient counseling, surgical planning, and intraoperative guidance. Intraoperative imaging technologies such as intracorporeal ultrasound, near-infrared fluorescent imaging, and intraoperative pathological examination can also be used to improve the outcomes following RAPN. Finally, artificial intelligence may play a role in the field of RAPN soon. RAPN is a complex surgery; however, many imaging technologies may play an important role in facilitating it.

1 June 2021 in Prostate International
Verified
Journal Article
Open access
JJJose L. Marenco Jimenez
Jose L. Marenco Jimenez
FCFrancesco Claps
Francesco Claps
JRJuan C. Ramón-Borja
Juan C. Ramón-Borja
JMJuan M. Mascarós Martinez
Juan M. Mascarós Martinez
AGAugusto W. Gutierrez
Augusto W. Gutierrez
JRJose Rubio-Briones
Jose Rubio-Briones
In recent years, transperineal biopsies gained popularity for prostate cancer diagnosis; lower infective complications and improved sampling of the prostate are the main advantages of this technique. One question that remains unclear is whether an initial transperineal biopsy confers a lower risk for rebiopsy compared with the transrectal approach. Six hundred seventy-one men were prospectively followed after an initial negative prostate biopsy for a median period of 49.50 (IQR: 37.62–61.17) months. Rebiopsy rate was analyzed attending to first biopsy approach (transrectal versus transperineal systematic) and clinical variables. Diagnostic rate was similar for transrectal and transperineal systematic biopsies. Targeted biopsies outperformed any systematic approach, and transperineal targeted in particular was superior to transrectal targeted. Rebiopsy rates were 15.4% and 5.26% for the transrectal and transperineal systematic groups, respectively. Prostate-specific antigen density and type of first biopsy were identified as rebiopsy predictors. Men undergoing transperineal systematic biopsies had a three times lower rate of rebiopsy over the study period compared with the traditional transrectal approach. This advantage could be added to the already described potential benefits of transperineal biopsies. Targeted biopsies had lower rebiopsy rate over the study period. Further innovations that decreased the cost of transperineal biopsies could favor this approach in the future.

31 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
GRGiulio Rossin
Giulio Rossin
FZFederico Zorzi
Federico Zorzi
PPPedro De Pablos-Rodríguez
Pedro De Pablos-Rodríguez
ABArianna Biasatti
Arianna Biasatti
JMJosè Marenco
Josè Marenco
FCFrancesco Claps
Francesco Claps
Sentinel node biopsy (SNB) for prostate cancer (PCa) represents an innovative technique aimed at improving nodal staging accuracy. The routinary adoption of this procedure in patients undergoing radical prostatectomy (RP) might be crucial to identify candidates who could effectively benefit from extensive pelvic lymph nodal dissection (ePLND). Despite some promising results, SNB for PCa is still considered experimental due to the lack of solid evidence and procedural standardization. In this regard, our narrative review aimed to analyze the most recent literature in this field, providing an overview of both the diagnostic accuracy measures and the oncological outcomes of SNB.

1 September 2010 in Reumatología Clínica
Verified
Journal Article
Closed access
JMJose L. Marenco
Jose L. Marenco
AFAntonio Fernandez-Nebro
Antonio Fernandez-Nebro